Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Porphyria Cutanea Tarda
Total 0 results
Nothing found
Sponsors and Collaborators
iCAD
Everett Meyer
GFI
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Nacuity Pharmaceuticals, Inc.
Kupfer, David J., M.D.
Aptis Medical
Hospital ASEPEYO Sant Cugat
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Agency for Science, Technology and Research
Apollo Neuroscience, Inc.
Hospital Durand, Argentina
Alma Lasers Inc.
ASST Cremona, Cremona
Mª Victoria Maestre Sanchez
Eurofins Genoma
RMIT University, Melbourne, Australia
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Neurophth Therapeutics Inc
Korean Society of Spine Surgery
View Full List
Medical Conditions
Chronic Constipation Symptoms
Splenic Trauma
Corneal Cross-Linking
Fever
T-LGL Leukemia
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Treatment Decisions
Disorder of Fluid Balance
Metachronous Adenoma
Rheumatoid Arthritis(RA)
Dienogest
Luteal Phase Support
Gastric Cancer Stage IIIB-IIIC
Recurrent Clear Cell Sarcoma of Soft Tissue
Scleredema
Immune-Mediated Inflammatory Disease
Major Liver Surgery
RISS Stage III Plasma Cell Myeloma
The Strength Properties of the Aorta in Vitro
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
View Full List
Drug Interventions
THC
RDX227675
Intravenous deferiprone
Olopatadine
GLPG1837 multiple ascending doses
Fospropofol disodium, propofol
TPN-101
Anticholinergic
OnabotulinumtoxinA
Camptosar
MLN2480
Intravenous Formulation of PD-0332991
Midazolam
Capecitabine and IMRT (if randomized to this arm)
Oxycodone/acetaminophen 5/325 mg
Standard of care (SOC) for COVID-19
PD-1/PD-L1 inhibitor
Desvenlafaxine
Letrozole
Capecitabine/cisplatin
View Full List
CROs by country
Contract Research Organizations in Benin
Contract Research Organizations in Colombia
Contract Research Organizations in Croatia
Contract Research Organizations in Ecuador
Contract Research Organizations in Georgia
Contract Research Organizations in Hungary
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Kuwait
Contract Research Organizations in Poland
Contract Research Organizations in Portugal
Contract Research Organizations in Tunisia
Contract Research Organizations in Türkiye
Contract Research Organizations in United Kingdom
CRO list by country
CROs in Moldova
SGS
PSI
SanaClis
BiTrial Clinical Research
Dokumeds
All CROs in Moldova
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe